2020 Q1 Form 10-Q Financial Statement

#000117184320003662 Filed on May 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1 2018 Q4
Revenue $3.323M $3.180M $2.780M
YoY Change 4.48% -9.64% -13.93%
Cost Of Revenue $1.389M $1.288M $1.240M
YoY Change 7.84% -11.21% -1.59%
Gross Profit $1.934M $1.892M $1.540M
YoY Change 2.2% -8.54% -21.83%
Gross Profit Margin 58.19% 59.49% 55.4%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $107.7K $98.66K $110.0K
YoY Change 9.2% -2.96% -21.43%
% of Gross Profit 5.57% 5.21% 7.14%
Depreciation & Amortization $40.52K $42.11K $50.00K
YoY Change -3.77% -14.34% 0.0%
% of Gross Profit 2.1% 2.23% 3.25%
Operating Expenses $107.7K $547.0K $650.0K
YoY Change -80.3% 4.36% 8.33%
Operating Profit $1.311M $1.246M $890.0K
YoY Change 5.15% -13.62% -35.04%
Interest Expense -$310.0K $300.0K -$190.0K
YoY Change -203.33% -433.33% -337.5%
% of Operating Profit -23.65% 24.07% -21.35%
Other Income/Expense, Net -$312.5K $301.4K
YoY Change -203.71% -397.77%
Pretax Income $998.0K $1.548M $690.0K
YoY Change -35.51% 15.36% -52.08%
Income Tax $207.7K $325.0K $110.0K
% Of Pretax Income 20.81% 21.0% 15.94%
Net Earnings $790.3K $1.223M $580.0K
YoY Change -35.36% 15.36% -43.14%
Net Earnings / Revenue 23.78% 38.45% 20.86%
Basic Earnings Per Share
Diluted Earnings Per Share $172.1K $265.8K $126.4K
COMMON SHARES
Basic Shares Outstanding 4.594M 4.594M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.850M $9.950M $8.170M
YoY Change -11.06% 0.0% -3.31%
Cash & Equivalents $790.2K $499.3K $550.1K
Short-Term Investments $8.060M $9.450M $7.620M
Other Short-Term Assets $230.0K $260.0K $360.0K
YoY Change -11.54% 18.18% 125.0%
Inventory $1.363M $1.325M $1.482M
Prepaid Expenses
Receivables $2.105M $1.605M $1.673M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $12.54M $13.14M $11.69M
YoY Change -4.57% -2.08% -1.38%
LONG-TERM ASSETS
Property, Plant & Equipment $744.9K $802.5K $827.9K
YoY Change -7.17% -11.92% -12.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.12K $25.94K $29.65K
YoY Change -57.14% -36.36% -50.15%
Total Long-Term Assets $756.1K $828.5K $857.6K
YoY Change -8.74% -12.97% -14.44%
TOTAL ASSETS
Total Short-Term Assets $12.54M $13.14M $11.69M
Total Long-Term Assets $756.1K $828.5K $857.6K
Total Assets $13.30M $13.97M $12.54M
YoY Change -4.81% -2.8% -2.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $32.09K $142.5K $186.8K
YoY Change -77.48% -49.95% -47.27%
Accrued Expenses $1.271M $1.277M $1.041M
YoY Change -0.46% 13.14% 18.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.572M $1.558M $1.366M
YoY Change 0.86% -18.43% -3.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.572M $1.558M $1.366M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.870M $1.820M $1.620M
YoY Change 2.75% -5.21% 10.96%
SHAREHOLDERS EQUITY
Retained Earnings $10.96M $11.69M $10.47M
YoY Change -6.2% -2.57% -0.05%
Common Stock $459.4K $459.4K $459.4K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.42M $12.15M $10.92M
YoY Change
Total Liabilities & Shareholders Equity $13.30M $13.97M $12.54M
YoY Change -4.81% -2.8% -2.4%

Cashflow Statement

Concept 2020 Q1 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income $790.3K $1.223M $580.0K
YoY Change -35.36% 15.36% -43.14%
Depreciation, Depletion And Amortization $40.52K $42.11K $50.00K
YoY Change -3.77% -14.34% 0.0%
Cash From Operating Activities $1.287M $1.532M $1.040M
YoY Change -15.95% -8.29% 33.33%
INVESTING ACTIVITIES
Capital Expenditures $1.048K $12.99K $0.00
YoY Change -91.93% -50.97% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$1.540M -$1.570M $1.320M
YoY Change -1.91% 20.77% -66.15%
Cash From Investing Activities -$1.545M -$1.583M $1.310M
YoY Change -2.35% 19.55% -66.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.530M
YoY Change -44.76%
NET CHANGE
Cash From Operating Activities 1.287M 1.532M 1.040M
Cash From Investing Activities -1.545M -1.583M 1.310M
Cash From Financing Activities -2.530M
Net Change In Cash -258.1K -50.88K -180.0K
YoY Change 407.32% -114.69% -300.0%
FREE CASH FLOW
Cash From Operating Activities $1.287M $1.532M $1.040M
Capital Expenditures $1.048K $12.99K $0.00
Free Cash Flow $1.286M $1.519M $1.040M
YoY Change -15.3% -7.61% 30.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 ug Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
34824
CY2019Q4 ug Accrued Annual Report Expenses Current
AccruedAnnualReportExpensesCurrent
64324
CY2020Q1 ug Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
311354
CY2019Q4 ug Accrued Distribution Fees Current
AccruedDistributionFeesCurrent
309190
CY2020Q1 ug Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
260374
CY2019Q4 ug Accrued Reserve For Outdated Material
AccruedReserveForOutdatedMaterial
231392
CY2020Q1 ug Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
7990644
CY2019Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Cost
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost
6446276
CY2020Q1 ug Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
8055289
CY2019Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Fair Value
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue
6867516
CY2020Q1 ug Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
64645
CY2019Q4 ug Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss
DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss
421240
CY2020Q1 ug Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
64645
CY2019Q4 ug Equity Securities Fvni Accumulated Unrealized Gain Loss
EquitySecuritiesFvniAccumulatedUnrealizedGainLoss
421240
CY2020Q1 ug Gain Loss From Trade In Of Equipment
GainLossFromTradeInOfEquipment
0.17
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000101295
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Trading Symbol
TradingSymbol
ug
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
UNITED GUARDIAN INC
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q1 ug Gain Loss From Trade In Of Equipment
GainLossFromTradeInOfEquipment
0.27
CY2020Q1 ug Increase Decrease In Dividends Payable
IncreaseDecreaseInDividendsPayable
-616
CY2019Q1 ug Increase Decrease In Dividends Payable
IncreaseDecreaseInDividendsPayable
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
32085
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
71385
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2105428
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2098411
CY2020Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
324000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
216000
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
126453
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
CY2020Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
86453
CY2019Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1271108
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1129126
CY2020Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
28000
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
46100
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
30750
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
48500
CY2020Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
137441
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
175433
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6646631
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6609818
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
20186
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
21178
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
20186
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
21178
CY2020Q1 us-gaap Assets
Assets
13297626
CY2019Q4 us-gaap Assets
Assets
12362812
CY2020Q1 us-gaap Assets Current
AssetsCurrent
12541566
CY2019Q4 us-gaap Assets Current
AssetsCurrent
11567281
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
CY2020Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
291603
CY2019Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
314163
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1048311
CY2020Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 27pt"><div style="display: inline; font-style: italic; font: inherit;">2.</div></td> <td style="text-align: justify">Basis of Presentation</td> </tr> </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 27pt">Interim condensed financial statements of the Company are prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;US GAAP&#x201d;) for interim financial information, pursuant to the requirements for reporting on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-Q and Regulation S-<div style="display: inline; font-style: italic; font: inherit;">X.</div> In the opinion of management, all adjustments considered necessary for the fair presentation of financial statements for the interim periods have been included. The results of operations for the <div style="display: inline; font-style: italic; font: inherit;">three</div>-month period ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020 (</div>also referred to as the &#x201c;first quarter of <div style="display: inline; font-style: italic; font: inherit;">2020&#x201d;</div>) are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of results that ultimately <div style="display: inline; font-style: italic; font: inherit;"> may </div>be achieved for any other interim period or for the year ending <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020. </div>The interim unaudited condensed financial statements and notes thereto should be read in conjunction with the audited condensed financial statements and notes thereto contained in our Annual Report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019.</div></div></div>
CY2020Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2840337
CY2019Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
2839289
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
790190
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
550135
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
499256
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-258121
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-50879
CY2020Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
699000
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4594319
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4594319
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4594319
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4594319
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
459432
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
459432
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1389331
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1288345
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
2012338
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
1933966
CY2020Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
150
CY2019Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
CY2020Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-356595
CY2019Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
262423
CY2020Q1 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
CY2019Q1 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-5229
CY2020Q1 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-356595
CY2019Q1 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
257194
CY2020Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-84012
CY2019Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
10856
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-84012
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10856
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
302843
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
386855
CY2019Q4 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
37500
CY2020Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
36250
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40519
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
42105
CY2020Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
141932
CY2019Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
142548
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.17
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.27
CY2020Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
6561823
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
3385891
CY2020Q1 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
6497178
CY2019Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
2964651
CY2020Q1 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
4482236
CY2019Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
4482236
CY2020Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
1493466
CY2019Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
3481625
CY2020Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
1493466
CY2019Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
3481625
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
998048
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1547713
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-67707
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
126453
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
207741
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
325019
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
150000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-39300
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-44305
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6025
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
141982
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
236316
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
145510
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-157380
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
57406
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
68068
CY2020Q1 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-165300
CY2019Q1 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-164163
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
886859
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
815768
CY2020Q1 us-gaap Inventory Net
InventoryNet
1362787
CY2019Q4 us-gaap Inventory Net
InventoryNet
1217277
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
413450
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
320507
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
35000
CY2020Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
35000
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
62478
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
81002
CY2020Q1 us-gaap Investment Income Net
InvestmentIncomeNet
44067
CY2019Q1 us-gaap Investment Income Net
InvestmentIncomeNet
44167
CY2020Q1 us-gaap Land
Land
69000
CY2019Q4 us-gaap Land
Land
69000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13297626
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12362812
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1571578
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1343059
CY2020Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
8055289
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
6867516
CY2020Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-356595
CY2019Q1 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
257194
CY2020Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-356595
CY2019Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
257194
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1545416
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1582533
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1287295
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1531654
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
790307
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1222694
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-312528
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
301361
CY2020Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
515275
CY2019Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
546962
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1310576
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1246352
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21662
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
38187
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11118
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14824
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1048
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12992
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3544368
CY2019Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
6049914
CY2020Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
36250
CY2019Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
227872
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
170466
CY2020Q1 us-gaap Prepaid Taxes
PrepaidTaxes
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
165300
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2000000
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
4480373
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7391573
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7390525
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
744942
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
780707
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-992
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2020Q1 us-gaap Reclassifications
Reclassifications
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0" cellspacing="0" style="; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; min-width: 700px;"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0; text-align: right"></td> <td style="width: 27pt"><div style="display: inline; font-style: italic; font: inherit;">5.</div></td> <td style="text-align: justify">Reclassifications</td> </tr> </table> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 23.05pt">Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on the previously reported net income.</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 23.05pt">&nbsp;</div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0 0pt 23.05pt">In accordance with ASC Topic <div style="display: inline; font-style: italic; font: inherit;">606</div> &#x201c;Revenue from Contracts with Customers&#x201d;, for the <div style="display: inline; font-style: italic; font: inherit;">three</div>-month period ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2019, </div>the Company reclassified certain sales rebates from Cost of Sales to Net Sales in the amount of <div style="display: inline; font-style: italic; font: inherit;">$101,706.</div> The reclassification had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on gross profit, net income, the provision for income taxes or earnings per share for the <div style="display: inline; font-style: italic; font: inherit;">three</div>-month period ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2019. </div>See &#x201c;Revenue Recognition&#x201d; below for further discussion regarding ASU Topic <div style="display: inline; font-style: italic; font: inherit;">606.</div> </div></div>
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
107732
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
98659
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10963773
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10173466
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3322914
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3180318
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
11423205
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
10632898
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4594319

Files In Submission

Name View Source Status
0001171843-20-003662-index-headers.html Edgar Link pending
0001171843-20-003662-index.html Edgar Link pending
0001171843-20-003662.txt Edgar Link pending
0001171843-20-003662-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_32.htm Edgar Link pending
f10q_051220p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ug-20200331.xml Edgar Link completed
ug-20200331.xsd Edgar Link pending
ug-20200331_cal.xml Edgar Link unprocessable
ug-20200331_def.xml Edgar Link unprocessable
ug-20200331_lab.xml Edgar Link unprocessable
ug-20200331_pre.xml Edgar Link unprocessable